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Background: Multidisciplinary care is a key enabler in the provision of high quality care for cancer patients. Despite
compelling evidence supporting their benefit to patients and for providers, multidisciplinary cancer conferences
(MCC) are not universally occurring. Team composition of MCC reflects the multidisciplinary nature of the body.
Lack of nursing input can have a negative impact on team decision making. The objective of this study was to
evaluate multidisciplinary care and adherence to national recommendations at a medium-sized hospital through a
clinical audit of cancer conferences and clinical records.
Methods: A total of 77 multidisciplinary cancer conferences were visited and 496 electronic health records were
reviewed. The regularity of meetings and multidisciplinary attendance were evaluated. Each electronic health record
was checked to verify documented prospective discussion before any treatment was started.
Results: Nine multidisciplinary teams meet on a weekly or biweekly basis at the hospital with an average number
of ten people and six different specialties represented. Average duration of meetings was 46.8 min. Though most
patients (64.5%) were discussed at some point at the relevant cancer conference, only 40% had a documented
multidisciplinary team discussion prior to the first treatment. Pathological stage (pTNM) was documented in 53.6%
of clinical records.
Conclusions: Nursing representatives should be included as usual attendees at cancer conferences. Prospective
discussion of all cancer cases should be encouraged. Use of checklists and systematic collection of key information,
specifically cancer staging, could improve clinical documentation in the electronic clinical record.
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Responding to growing concerns regarding safety, qual-
ity and efficacy of cancer care in the United States, the
Institute of Medicine (IOM) commissioned a compre-
hensive review in the late 1990s [1]. In its follow-up
report in 2000 the IOM recommended among other
things: identification of a core set of evidence-based
quality measures, standardization of reporting with re-
gard to disease stage and reporting performance data.
The IOM advocated for the enhancement of cancer care
data systems through those mechanisms [2]. These re-
ports have inspired several further national cancer plans.
In Spain, a first national cancer plan was launched in* Correspondence: arcasado@salud.madrid.org
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distribution, and reproduction in any medium2006 [3] and was reviewed in 2009 [4]. Prospective
evaluation of every cancer patient by a multidisciplinary
team is recommended in both documents.
The quality of cancer care can be precisely defined and
accurately measured. But there are many different per-
spectives to consider. Structural characteristics include
clinician (board certification, distribution of specialties,
etcetera) and organizational characteristics (staffing pat-
terns, schedules, etcetera). Structural characteristics are
necessary to provide good care but are insufficient to en-
sure excellent quality. Research suggests that outcomes
are improved when patients receive cancer care from a
highly functioning multidisciplinary care team (another
structural characteristic). Multidisciplinary cancer confer-
ences are not universally occurring, despite compelling
evidence supporting their benefit to patients and for
providers [5]. The evidence shows that the roles played byntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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(MDT) are varied, with lower importance placed on the
input of nursing personnel [6]. Regarding multidisciplinary
care, a high degree of variability could be expected in
Spain in the context of a decentralized health care system
[7]. In Spain there is not any kind of accreditation for
hospitals providing cancer care, though in Catalonia, spe-
cialized cancer surgery has recently been limited to high-
volume hospitals.
Monitoring MDT meetings activity ensures that con-
ferences provide consultative services for patients to for-
mulate an effective treatment plan and offer education
to physicians and allied health professionals in attend-
ance. The Hospital Universitario de Fuenlabrada (HUF)-
Cancer Program requires routine evaluation of cancer
conference activity in each of these five areas: 1) confer-
ence frequency, 2) multidisciplinary attendance, 3) total
case presentation, 4) prospective case presentation, and
5) cancer staging.
Measurement and reporting of quality of care is an essen-
tial part of the conceptual framework for quality improve-
ment. Our objective was to evaluate the multidisciplinary
care of cancer patients and adherence to the Spanish
cancer plan recommendations (‘Estrategia en Cáncer del
Sistema Nacional de Salud’) [3,4] at a medium-sized Spanish
hospital.
Methods
The HUF has been the general hospital in the southwest
region of the Comunidad de Madrid since June 2004. It
has 406 beds. A unique electronic medical record is used.
Audit of multidisciplinary team meetings
The Cancer Committee appointed four oncology nurses
by March 2011 in order to audit the cancer conferences.
Nurses were not usual members of the teams, so they
could act as external evaluators. As hospital workers in-
volved in patient care, they were allowed to review the
medical information discussed at the meetings. The
Cancer Committee provided the evaluators with a calen-
dar of the annual cancer conferences schedule and the
venue for each meeting.
External evaluators are responsible for checking: 1)
that the conference was held at the place and time as
scheduled in the calendar, 2) the starting and ending
time, 3) the number of attendees, 4) the specialty of the
attendees, and 5) the number of cases discussed.
Audit of clinical records
All the 2009 incident cases registered by March 2011
(hospital-based tumor registry) were scheduled to be
reviewed in 2011 by the Cancer Committee members (in
parallel with the process of the MDT meetings audit).
The criteria to be reviewed had been previously agreedupon by the members of the Cancer Committee accord-
ing to the Hospital-Cancer Program: 1) the recommen-
dation made by the MDT was documented in the
clinical record; 2) the discussion was held before any
treatment had been done; 3) the TNM staging should be
documented; 4) the diagnostic interval (date of diagnosis
minus date of first contact); and 5) the therapeutic inter-
val (date of first treatment minus date of diagnosis). The
diagnostic and therapeutic intervals were calculated for
review purposes. Date of first contact is the first time
the patient contacts the hospital (that is, the date the pa-
tient asks for an appointment and not the date of the ap-
pointment). The date of diagnosis required not only
pathologic confirmation (when possible) but also the ne-
cessary work-up for decision making.
Results
Audit of cancer conferences
Nine cancer conferences were identified by the Cancer
Committee: breast, dermatology, gastrointestinal (G-I),
gynecology, head and neck (H and N), hematology, lung,
sarcomas and urology. Five conferences (breast, G-I, lung,
hematology and urology) were planned on a weekly basis
whereas the other four (dermatology, gynecology, H and
N, and sarcomas) were planned every two weeks. Seventy-
seven meetings were visited between April and October
2011. All the meetings were held at the planned location,
starting with a median delay of 5.6 min (−5 - +15). Aver-
age duration of the meetings was 46.8 min (15 to 95).
Average number of attendees was 10.4 (3 to 31). Average
number of different represented specialties was 6.1 (3 to
11). There were no nurses among the regular attendees,
although during the audit period nurses were present as
external evaluators.
A post-hoc analysis tried to identify if the so-called core
members were present in all meetings. To define core
members, we referred to ‘Multidisciplinary Cancer Care
Tools’ [8]. The participants required to make a qualified
decision (core-members) were: the medical oncologist, the
radiation oncologist, the surgical oncologist, the patholo-
gist and the radiologist. The hematology cancer conference
did not require the attendance of a surgical oncologist and
required the presence of a hematologist instead of a med-
ical oncologist. All core members were present in 42 out
of 77 visited meetings (54%).
The number of cases discussed per meeting varied
among the different cancer conferences and was higher
for conferences reviewing high-incidence tumors such as
breast, lung and G-I (see Figure 1). The average cases
discussed per meeting was 7.8. The average duration of
discussion per case was 6 minutes. For this analysis it
should be clarified that case does not necessarily mean
patient (some patients were discussed several times). A
specific retrospective analysis was done to distinguish
Figure 1 Cases per meeting.
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gastrointestinal and breast cancer conference. The 526
cases in the breast cancer conference were for 129 pa-
tients, whereas the 162 cases in the gastrointestinal can-
cer conference were for 149 patients.
Table 1 shows the data per cancer conference.
Audit of clinical records
A total of 496 cases were generated by the hospital-based
tumor registry. Ten members of the Cancer Committee
reviewed the e-health records. A total of 320 (64.5%)
patients were discussed in different cancer conferences
(according to the minutes of the meetings). A total of 259
(52%) patients had written documentation of the MDT
recommendation in the clinical record. A total of 198
(40%) patients had had an MDT discussion prior to the






Breast 19 +10 70 (40 to 95) 10 (4 to 13)
Dermatology 3 +5 28 (15 to 40) 7 (6 to 7)
Gastrointestinal 12 −5 51 (40 to 75) 26 (7 to 31)
Gynecology 5 +5 46 (35 to 75) 7 (5 to 8)
Head and neck 7 +5 49 (35 to 65) 10 (10 to 11)
Hematology 11 +15 37 (12 to 75) 8 (5 to 11)
Lung 12 +6 46 (30 to 75) 8 (3 to 11)
Urology 3 0 48 (30 to 75) 14 (13 to 15)
Sarcomas 5 +10 51 (40 to 75) 6 (4 to 9)
Total 77 +5.6 min 46.8 min 10.4
aAverage (range).
bThis analysis could not be done for every cancer conference.Only TNM staging was considered. Clinical staging
(cTNM) was recorded in 118 (23.8%) and pTNM in 266
(53.6%) of the clinical records.
The median diagnostic delay was 33 days and the
median therapeutic delay was 21 days.
Table 2 shows the clinical record data per cancer
conference.
Discussion
Cancer care can be complex. Due to the large number
and range of healthcare providers who may be involved,
there is potential for poor communication and poor co-
ordination of care. Multidisciplinary care (MDC) has
been identified as a key enabler in the provision of high-
quality treatment and care for cancer patients [9].
The evidence for improved survival as an impact of
multidisciplinary cancer care is not definitive. A ScottishSpecialties
represented
Qualified quorum Cases Time (min)
per case+
Patientsb
7 (4 to 10) 13 526 3 (2 to 4) 129
6 (5 to 7) 2 15 6 (3 to 7) -
8 (5 to 11) 10 162 4 (2 to 7) 149
5 (3 to 6) 2 53 4 (3 to 6) -
7 (6 to 8) 7 64 5 (3 to 10) -
5 (4 to 6) 4 47 9 (6 to 13) -
5 (3 to 7) 0 173 3 (2 to 5) -
7 (6 to 8) 1 19 7 (4 to 12) -
5 (4 to 8) 3 21 13 (8 to 18) -
6.1 42 1080 6 min -



















General 496 320 (64.5%) 198 (40%) 259 (52%) 118 (23.8%) 266 (53.6%) 33 21
Gastrointestinal 147 124 (84.3%) 87 (59.1%) 116 (78.9%) 58 (39.4%) 89 (60.5%) 30 21
Breast 46 43 (93%) 38 (82.6%) 43 (93%) 9 (19.5%) 35 (76%) 28 28
Lung 68 36 (52.9%) 15 (21.7%) 10 (14.5%) 11 (16.1%) 24 (35.3%) 13 10
Hematology 33 14 (42%) 7 (21%) 8 (24%) na na na na
Urology 81 46 (56.7%) 15 (18.5%) 28 (34.5%) 11 (13.5%) 52 (64.2%) 46 33
Gynecology 23 19 (82.6%) 10 (43.5%) 16 (69.6%) 5 (21.7%) 16 (69.6%) 34 31
H and N 28 16 (57%) 8 (28.6%) 8 (28.6%) 11 (39.3%) 19 (67.8%) 46 19
Sarcomas 5 5 (100%) 2 (40%) 1 (20%) 1 (20%) 3 (60%) 41 15
Melanoma 16 14 (87.5%) 2 (40%) 11 (68.7%) 3 (18.7%) 11 (68.7%) 13 56
Other: Unknown origin, Thyroid,
Brain, Peritoneum
41 4 (9.7%) 2 (4.9%) 1 (2.4%) 1 (2.4%) 7 (17.1%) 50 23
H and N, head and neck; na, not available due to the specific characteristics of hematological cancers. MDT (multidisciplinary team); cTNM (clinical staging); pTNM
(pathological staging).
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cancer survival to MDC [10]. A Norwegian study also
showed a twofold increase in survival of upper gastro-
intestinal patients [11]. However an American study in
the Veterans Affairs health system provides some evi-
dence against that previous statement [12]. These studies
did not have the strength of randomized controlled tri-
als, which are no longer possible because of the prolific
introduction of the multidisciplinary approach. Nonethe-
less, MDC is purported in the literature to offer many
benefits. It reduces time to diagnosis and treatment, im-
proves adherence to guidelines, improves inclusion in
clinical trials, improves patient satisfaction and improves
education and collegiality for members of the MDT [9].
Cancer conferences are used for the attainment of ac-
creditation [13].
To be considered as an additional structural character-
istic of the hospital, every meeting should be periodic
and fixed at a preplanned location. MDT members
should have dedicated time included in their job plans
to prepare and attend MDT meetings. These meetings
should be held during core hours and should not clash
with related clinics that members need to attend [14].
Organizational factors related to the structure of the
MDT meeting are associated with variation in the likeli-
hood of reaching a treatment decision. A recent study
revealed that an increased number of cases per meeting
and team members in attendance, as well as more time
per case, were associated with better teamwork [15].
Our results could help other organizations to estimate
the protected time for this purpose. Regarding time
per case, we obtained similar figures to the published
ones for GI meetings (around 4 minutes in the United
Kingdom) [16], but quite longer for urological meetings(around 2 minutes in the UK) [14]. Perhaps it is not sur-
prising that the longest time devoted per case was for
low incidence and complex tumors such as sarcomas
(Figure 2). One of the well-known advantages of cancer
conferences is the establishment of clinical management
protocols and development of treatment pathways [17].
This approach works better in high-incidence tumors
such as lung, breast or colorectal cancer.
The IOM report, the National Institutes of Health
(NIH) guidance as well as the ‘Estrategia en Cáncer’ rec-
ommend that every cancer patient should be discussed
at an MDT before a treatment is started. However, many
professionals argue that this approach is not feasible be-
cause of time and economic restrictions [18]. Though
most cancer cases in this audit were discussed at some
point by an MDT, fewer than half of the overall popula-
tion were prospectively reviewed.
Multidisciplinary composition is based on the presence
of different specialties in the meeting. An effective mul-
tidisciplinarity should include real participation and not
only physical presence. But evaluation of this functional
aspect was beyond the scope of our evaluation. Our
Hospital-Cancer Program did not establish whether the
presence of some specialists was specifically required.
We performed a post-hoc analysis in order to under-
stand whether we would be compliant for a qualified
quorum [8]. One of the findings was that because thor-
acic surgery was not an in-house discipline, a qualified
quorum could not be reached in any of the lung cancer
conferences. But even including that conference, 54% of
the audited meetings were attended by the tumor-specific
minimum core team, much more than the 1% obtained in
a recent survey in Australia [19] and similar to the 49.3%
observed in The Netherlands [20].
Figure 2 Time per case and cases per meeting.
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cess of an MDT. Their role should be to coordinate and
develop a plan of care with physicians, coordinate ap-
pointments, disseminate information and provide infor-
mation and education to patients and family members.
It has been demonstrated that a bias towards biomedical
information occurred when nurses do not participate
[21]. Nurses make a valuable contribution to clinical de-
cision making in the MDT meeting with particular focus
on patients’ comorbid health, psychosocial and social is-
sues [22]. Dominance of the medical profession in the
healthcare system is one of the main barriers to this kind
of collaborative practice [23].
The medical record is an essential source of informa-
tion on the delivery of care as well as a measure of profi-
ciency [24]. The use of an electronic clinical record
(ECR) has potential to decrease the amount of missing
clinical information but cannot solve all the problems.
In fact, we found some difficulties in locating some spe-
cific information because there was no structured pro-
cedure for collecting information in the ECR. Essential
information should be codified, easily found and ready
for semantic interoperability. A poor medical recording
performance is related to a poor medical care perform-
ance [25], and poor physical documentation could falsely
suggest that rates are worse than they really are [26].
The lack of key information in the ECR, such as per-
formance status (PS) assessment or TNM, staging could
be overcome through checklists and pro-forma practices.
A locally agreed minimum dataset of information about
patients to be discussed should be collated and summa-
rized prior to MDT meetings and it should be in line
with data items that are in existing national datasets. We
propose the use of a checklist for MDT discussion sinceit has been considered that the recommendations are only
as good as the information on which they are based.
Cancer staging is a process that describes the anatomic
extent of a tumor. It is also a prognostic variable and al-
lows comparability. It is universally accepted that staging
is an essential component of cancer management. It
should be considered before deciding a treatment, and it
should be explicitly documented. Documentation of clin-
ical and pathological staging is considered a quality indi-
cator also linked to the clinical record quality. Whereas
clinical staging should always be possible, pathological
staging requires a previous resection. On the other hand,
TNM staging is not accepted for all cancers (for ex-
ample, hematological cancers are not TNM staged). For
our analysis, standards would not be 100% because of
these considerations. But we still think that clinical sta-
ging documentation was clearly insufficient in our audit.
A lack of appropriate skill or motivation is the most fre-
quent cause for an inaccurate staging [27]. The National
Cancer Institute of Canada adopted a national policy in
the 1990s to consider staging a standard of care [28].
Motivation program have demonstrated usefulness in
this setting [29].
In our audit, more than half of the cases (64.5%) were
reviewed by the relevant MDT, with the decision docu-
mented in the clinical record in 52% of cases. These
figures compare favorably with the ones obtained in 2007
by this Cancer Committee, when 41% of the cases had been
discussed. Only 40% of the cases overall were prospectively
discussed. This was the main finding of this audit, with
improvement clearly being necessary for our standards.
Diagnostic and therapeutic delays are not comparable
because of our particular definition of date of diagnosis
requiring complete work-up. These figures will be more
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for use in comparisons with other settings. In any case,
they also compare favorably with other published data [30].
We have to acknowledge some weaknesses in our evalu-
ation. We reviewed the 2009 registered cases by March
2011, but additional cases were subsequently registered
(up to 869) because of the retrospective nature of cancer
registration. In this regard we recognize a selection bias.
We analyzed some quality criteria related to MDC, but
some others, such as documentation of familial anteced-
ents or prognostic indicators (that is, PS, preoperative car-
cinoembryonic antigen, etcetera) in the clinical record
were not analyzed. And probably, the main weakness of
this study was the lack of information about the decision-
making process and the degree of implementation of the
recommendations made by the MDT. This aspect would
have required a different methodological approach.
Conclusions
To sum up, we can conclude that nine site-specific, multi-
disciplinary teams meet regularly on a weekly or biweekly
basis at the Hospital Universitario de Fuenlabrada. The
absence of nursing representatives was the main finding
regarding team composition. Most cases of cancer were
reviewed by an MDT, but only 40% were discussed before
any treatment was initiated. Clinical documentation im-
provement is necessary. We propose the use of checklists
for MDT discussion. Electronic health records require or-
ganizations to establish standards for functionality, data
representation and interoperability. Key information should
be collected in predefined locations.
Clinical audits are seen as one approach to improving
the quality of patient care. Sharing knowledge and ex-
pertise on different models for comprehensive and inte-
grated cancer care and, in particular, organization of
care, are actions recommended by Commission of the
European Communities [31]. A coordinated team-based
cancer care is still advocated by the latest relevant IOM
report [32], 15 years after the publication of the trans-
formative ‘Ensuring Quality Cancer Care’ [1].
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